Evidence map›Paper›PMID 39546056›Full record

ArticleFamilial cancer2024

Germline pathogenic variants in RNF43 in patients with and without serrated polyposis syndrome.

Heidi Hesselø Brinch, Anna Byrjalsen, Zuzana Lohse, Andreas Ørslev Rasmussen, John Gásdal Karstensen, Britta Schlott Kristiansen, Anne Marie Jelsig

Abstract read
In one paragraph

Article in Familial cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Heidi Hesselø BrinchDepartment of Clinical Genetics, Copenhagen University Hospital, Copenhagen, Denmark.
Anna ByrjalsenDepartment of Clinical Genetics, Copenhagen University Hospital, Copenhagen, Denmark. anna.byrjalsen@regionh.dk.
Zuzana LohseDepartment of Clinical Genetics, Zealand University Hospital, Roskilde, Denmark.
Andreas Ørslev RasmussenDepartment of Genomic Medicine, Copenhagen University Hospital, Copenhagen, Denmark.
John Gásdal KarstensenDanish Polyposis Register, Gastro Unit, Copenhagen University Hospital - Amager and Hvidovre and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
Britta Schlott KristiansenDepartment of Clinical Genetics, Odense University Hospital, Odense, Denmark.
Anne Marie JelsigDepartment of Clinical Genetics, Copenhagen University Hospital, Copenhagen, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serrated Polyposis Syndrome (SPS) is characterized by multiple and/or large serrated polyps in the colon and an increased risk of colorectal cancer (CRC). The etiology is largely unknown, but in a subset of patients with SPS, monoallelic pathogenic variants in RNF43 are detected. To date, however, the penetrance and phenotypic spectrum of patients carrying pathogenic variants (PV) in RNF43 are poorly described. We present eight patients both with and without serrated polyps from four unrelated families with likely pathogenic variants (LPV) in RNF43 and compare the results to current literature. The patients were referred to genetic counseling due to suspicion of hereditary cancer. They underwent genetic testing with custom NGS gene panels including RNF43 as part of a routine genetic work-up. Three LPVs, one multi-exon deletion and two nonsense variants, were detected in four families. Family I had a history of CRC and serrated polyps, but in the three other families (II‒IV) there was no history of CRC or serrated polyps. Colonoscopies in the probands of these families did not reveal any serrated polyps and/or CRC despite some of them being relatively old. Our findings suggest that the penetrance of RNF43-related disease is much lower than previously thought, and raise questions about the connection between RNF43 and disease. The results highlight the complexity of genetic counseling in RNF43 positive families- particularly in families without polyposis. Further research is needed to elucidate the role of RNF43 in the risk of SPS and CRC.

Indexed as

Germ-Line MutationPedigreeUbiquitin-Protein LigasesAdenomatous Polyposis ColiAdultAgedColonic PolypsColorectal NeoplasmsFemaleGenetic Predisposition to DiseaseGenetic TestingHumansMaleMiddle AgedPenetranceRNF43 protein, humanUbiquitin-Protein LigasesCancer geneticsCancer predisposition syndromeColorectal cancerPolyposisRNF43Serrated polyposis syndrome

Identifiers

PMID39546056
PMCPMC11568000

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.